Vertebroplasty versus radiotherapy as palliative treatment of vertebral metastases of multiple myeloma (M. Kahler)

Vertebroplasty versus radiotherapy as palliative treatment of vertebral metastases of multiple myeloma (M. Kahler) - Vertebroplasty of M. Kahler vertebral metastases

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30539

Enrollment

104

Registered

2007-03-15

Start date

2007-03-26

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone cancer wervel metastase

Interventions

The control group will receive the standard treatment, radiotherapy. The experimental group will receive vertebroplasty of the affected vertebrae * the vertebrae will be filled with bone cement via

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. persistent pain caused by vertebral metastases from myeloma (including plasmacytoma) with VAS score >4 (scale: 1-10) 2. informed consent 3. older than 18 years

Exclusion criteria

Exclusion criteria: 1. >4 affected vertebrae 2. vertebral fracture through back wall with retropulsion that consumes more than 33% of the spinal channel 3. Myelum compression with neurological degeneration: Frankel A/B 4. Epiduritis 5. Incorrigible coagulopathy 6. Karnofsky score

Design outcomes

Primary

Measure	Time frame
Degree of pain reduction. Additionally initial technical success, complications, quality of life, mortality, and costs.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)